{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:43:16Z","timestamp":1790674996560,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ijrobp.2017.11.022","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T19:15:42Z","timestamp":1511378142000},"page":"738-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors"],"prefix":"10.1016","volume":"100","author":[{"given":"H.","family":"Tekatli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Duijm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Oomen-de Hoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Verbakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Schillemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Slotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Nuyttens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Senan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.ijrobp.2017.11.022_bib1","doi-asserted-by":"crossref","first-page":"vi89","DOI":"10.1093\/annonc\/mdt241","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Vansteenkiste","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib2","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1016\/j.jtho.2016.11.369","article-title":"OA24.05 The Nordic HILUS-Trial\u2013first report of a phase II trial of SBRT of centrally located lung tumors","volume":"12","author":"Lindberg","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijrobp.2015.10.040","article-title":"Primary study endpoint analysis for NRG Oncology\/RTOG 0813 trial of stereotactic body radiation therapy (SBRT) for centrally located non-small cell lung cancer (NSCLC)","volume":"94","author":"Bezjak","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13014-016-0732-5","article-title":"SBRT for centrally localized NSCLC\u2013what is too central?","volume":"11","author":"Roesch","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib5","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.prro.2015.09.012","article-title":"Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree","volume":"6","author":"Haseltine","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jtho.2016.03.008","article-title":"Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \u201cultracentral\u201d non\u2013small cell lung cancer","volume":"11","author":"Tekatli","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib7","first-page":"3136","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline","volume":"30","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","article-title":"Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Ettinger","year":"2017","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.radonc.2011.12.023","article-title":"Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors","volume":"102","author":"Nuyttens","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2007.10.053","article-title":"Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer","volume":"70","author":"Lagerwaard","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2015.09.028","article-title":"Stereotactic ablative radiotherapy (SABR) for central lung tumors: Plan quality and long-term clinical outcomes","volume":"117","author":"Tekatli","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijrobp.2005.05.045","article-title":"Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer","volume":"63","author":"Underberg","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2009.05.020","article-title":"Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs","volume":"93","author":"Verbakel","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/erd.12.35","article-title":"The CyberKnife radiosurgery system for lung cancer","volume":"9","author":"Nuyttens","year":"2012","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2010.10.003","article-title":"Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity","volume":"97","author":"Ong","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2013.10.011","article-title":"Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs","volume":"109","author":"Bongers","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib17","series-title":"Basic Clinical Radiobiology","author":"Joiner","year":"2009"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib19","series-title":"Statistical Methods for the Social Sciences","author":"Agresti","year":"2009"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijrobp.2009.04.048","article-title":"Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model","volume":"77","author":"Robertson","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semradonc.2015.11.002","article-title":"Dose and volume of the irradiated main bronchi and related side effects in the treatment of central lung tumors with stereotactic radiotherapy","volume":"26","author":"Duijm","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijrobp.2013.06.2055","article-title":"Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree","volume":"87","author":"Karlsson","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13014-016-0608-8","article-title":"Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases","volume":"11","author":"Lischalk","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.11.022_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1756-8722-3-39","article-title":"CyberKnife for hilar lung tumors: Report of clinical response and toxicity","volume":"3","author":"Unger","year":"2010","journal-title":"J Hematol Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161734141X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161734141X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T18:57:17Z","timestamp":1635706637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161734141X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S036030161734141X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.11.022","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}